Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing
468
MEMORANDUM in Opposition re #445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims filed by Amgen Inc.. (Attachments: #1 Appendix A)(Rich, Patricia)
<![CDATA[
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Doc. 468 Att. 1
Case 1:05-cv-12237-WGY
Document 468-2
Filed 06/06/2007
Page 1 of 3
APPENDIX A DISCOVERY CITED IN SUPPORT OF ALLEGATIONS OF INEQUITABLE CONDUCT NEW ALLEGATIONS OF INEQUITABLE CONDUCT SINCE THE CLOSE OF FACT DISCOVERY 1
Inequitable Conduct Relating to the Baron-Goldwasser Clinical Study and Related Prior Art
DOCUMENTS CITED IN SUPPORT OF EACH NEW ALLEGATION
DATE DOCUMENTS PRODUCED TO ROCHE
AM-ITC Documents: 00097004-18 00084770-80 00097005 00245727-29 00084770-80 00245727-29 00557514-27 00554114-25 00554114 00554117 00573885-903 00900641-648 00849306-341 00849307 00849306-41 00900552-553 00900525-640 00900641-648 00900823-836 00997385-92 00900550-55 00900629-36 00900641-43 00997385-92 00906488 00899764 00900823-26
Date Produced: 5/30/2006
5/31/2006
6/1/2006
Inequitable Conduct Relating to the Sulfate Content of EPO
AM-ITC Documents: 00067214-259
Date Produced: 5/30/2006 Date Produced: 5/30/2006
Inequitable Conduct Relating to Human EPO Fragments
AM-ITC Documents: 00072323-44 00072302-27 00072538-59
These allegations appear for the first time in Roche's May 1 Second Supplemental Response to Amgen Inc.'s Interrogatory No. 26, or in Roche's May 23 Proposed Second Amended Answer and Counterclaims
1140885_1.DOC
1
1
Dockets.Justia.com
Case 1:05-cv-12237-WGY
Document 468-2
Filed 06/06/2007
Page 2 of 3
00071306-31 00071332-61 00071642-56 00071657-79 00071995-2010 00072060-96 00072249-95 00072249-95 00072274-83 00072262 00072302-22 000723315 00072320 00071306-331 00072538-559 00071995-2010 00138725-55 00138725-755 00145452534 00211638 00596041-42 Misrepresentations and Omissions Regarding Molecular Weight AM-ITC documents: 00092249-60 000092135 00091218 00092870 00311606 00312411-12 00312754 00312455-73 00312260-71 00312441-45 00312283 00312291-92 00601553-60 01072474-501 01072482 00898341 00987639-49 Letter from Ross to Rycroft Inequitable Conduct Relating to Dr. Strickland's Inventive Contributions and Amgen's View of Obviousness of EPO/HSA Preparations AM-ITC Documents: 5/31/2006 Date Produced: 5/30/2006
5/31/2006 6/1/2006
3/27/2007 Date Produced:
00932278-285
6/1/2006
Inequitable Conduct Relating to Inventive Contribution
Documents: Lin Tr.
Date Produced: 3/27/07
Case 1:05-cv-12237-WGY
Document 468-2
Filed 06/06/2007
Page 3 of 3
Intent to Deceive the PTO to Secure Additional Patents and Claims to Extend Amgen's Monopoly Beyond the Original `008 Patent Inequitable Conduct Relating to "PEG-EPO" Prior Art Inequitable Conduct Regarding Use of Probes
AM-ITC Documents: 00906512 None None
Date Produced: 6/1/2006 None None
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
